Ono Pharmaceutical Co Ltd banner

Ono Pharmaceutical Co Ltd
TSE:4528

Watchlist Manager
Ono Pharmaceutical Co Ltd Logo
Ono Pharmaceutical Co Ltd
TSE:4528
Watchlist
Price: 2 452 JPY -0.99%
Market Cap: ¥1.2T

Multiples-Based Value

The Multiples-Based Value for Ono Pharmaceutical Co Ltd (4528) under the Base Case is hidden JPY. Compared with the current market price of 2 452 JPY, the stock appears hidden .

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Ono Pharmaceutical Co Ltd Multiples-Based Value
LOCKED
Unlock
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Ono Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Ono Pharmaceutical Co Ltd
TSE:4528
1.2T JPY 2.2 18.3 9.2 13.6
US
Eli Lilly and Co
NYSE:LLY
871.6B USD 13.4 42.3 28.6 30.5
US
Johnson & Johnson
NYSE:JNJ
578.1B USD 6.1 21.5 14.9 18.3
CH
Roche Holding AG
SIX:ROG
248.4B CHF 4.1 19.7 11.6 13.1
UK
AstraZeneca PLC
LSE:AZN
231.4B GBP 5.2 30 16.6 23.4
US
Merck & Co Inc
NYSE:MRK
296.9B USD 4.5 16 9.9 12.1
CH
Novartis AG
SIX:NOVN
230.8B CHF 5.1 20.6 12.7 16.4
IE
Endo International PLC
LSE:0Y5F
244.4B USD 105.4 -83.6 386.8 970
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK 3.6 11 8.1 9.5
US
Pfizer Inc
NYSE:PFE
154.1B USD 2.5 19.9 7.7 10.2
UK
GlaxoSmithKline PLC
LSE:GSK
89.3B GBP 2.7 15.4 8.4 10.4
P/E Multiple
Earnings Growth PEG
JP
Ono Pharmaceutical Co Ltd
TSE:4528
Average P/E: 21.5
18.3
9%
2
US
Eli Lilly and Co
NYSE:LLY
42.3
31%
1.4
US
Johnson & Johnson
NYSE:JNJ
21.5
8%
2.7
CH
Roche Holding AG
SIX:ROG
19.7
14%
1.4
UK
AstraZeneca PLC
LSE:AZN
30
25%
1.2
US
Merck & Co Inc
NYSE:MRK
16
14%
1.1
CH
Novartis AG
SIX:NOVN
20.6
14%
1.5
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -83.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
11
0%
N/A
US
Pfizer Inc
NYSE:PFE
19.9
22%
0.9
UK
GlaxoSmithKline PLC
LSE:GSK
15.4
14%
1.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
JP
Ono Pharmaceutical Co Ltd
TSE:4528
Average EV/EBITDA: 46.8
9.2
9%
1
US
Eli Lilly and Co
NYSE:LLY
28.6
21%
1.4
US
Johnson & Johnson
NYSE:JNJ
14.9
2%
7.5
CH
Roche Holding AG
SIX:ROG
11.6
6%
1.9
UK
AstraZeneca PLC
LSE:AZN
16.6
12%
1.4
US
Merck & Co Inc
NYSE:MRK
9.9
4%
2.5
CH
Novartis AG
SIX:NOVN
12.7
5%
2.5
IE
E
Endo International PLC
LSE:0Y5F
386.8
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
8.1
2%
4.1
US
Pfizer Inc
NYSE:PFE
7.7
-8%
N/A
UK
GlaxoSmithKline PLC
LSE:GSK
8.4
3%
2.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
JP
Ono Pharmaceutical Co Ltd
TSE:4528
Average EV/EBIT: 102.5
13.6
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
30.5
22%
1.4
US
Johnson & Johnson
NYSE:JNJ
18.3
6%
3.1
CH
Roche Holding AG
SIX:ROG
13.1
6%
2.2
UK
AstraZeneca PLC
LSE:AZN
23.4
21%
1.1
US
Merck & Co Inc
NYSE:MRK
12.1
6%
2
CH
Novartis AG
SIX:NOVN
16.4
9%
1.8
IE
E
Endo International PLC
LSE:0Y5F
970
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
9.5
2%
4.8
US
Pfizer Inc
NYSE:PFE
10.2
-4%
N/A
UK
GlaxoSmithKline PLC
LSE:GSK
10.4
5%
2.1
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett